2016-09-15T14:05:14-05:00 2016-06-30 410746749 CLIFTONLARSONALLEN LLP 1301 W 22ND ST STE 1100 OAK BROOK IL 60523 990 2015-07-01 731386920 GATEWAY FOR CANCER RESEARCH GATE 8473427450 1336 BASSWOOD ROAD SCHAUMBURG IL 60173 TERESA HALL BARTELS PRESIDENT 5473427450 2016-09-09 1 GREGORY S ADAMS P00095597 6305738600 2015 2017-02-10 21:41:12Z TERESA HALL BARTELS 1336 BASSWOOD ROAD SCHAUMBURG IL 60173 4154045 0 X GATEWAYCR.ORG X 1991 OK TO FIND AND FUND CLINICAL CANCER RESEARCH. 20 20 0 0 0 0 3036651 3013245 0 0 352043 433285 0 0 3388694 3446530 3907418 6158037 0 0 0 0 0 0 0 93468 115338 4000886 6273375 -612192 -2826845 12863957 12621020 5572657 8060497 7291300 4560523 X TO FUND MEANINGFUL AND BREAKTHROUGH CLINICAL TRIALS WORLDWIDE THAT HELP PEOPLE LIVING WITH CANCER TO FEEL BETTER, LIVE LONGER AND CONQUER CANCER TODAY! 0 0 6241236 6158037 GATEWAY FOR CANCER RESEARCH (FORMERLY KNOWN AS CANCER TREATMENT RESEARCH FOUNDATION OR CTRF), A NON-PROFIT 501(C)(3) ORGANIZATION, WAS ESTABLISHED IN 1991 TO PROMOTE RESEARCH THROUGH THE TREATMENT PROCESS AND SUPPORT PROGRESSIVE MOLECULAR, NUTRITIONAL AND IMMUNOLOGICAL RESEARCH PROGRAMS THAT MORE TRADITIONAL CANCER RESEARCH INSTITUTIONS MAY NOT FUND. GATEWAY IS DEDICATED TO ADVANCING INNOVATIONS IN THE SCIENTIFIC COMMUNITY AND SPEEDING THEM TO THE CANCER PATIENT'S BEDSIDE. THE WORK OF GATEWAY IS ABOUT GIVING CANCER PATIENTS THE ABILITY TO LIVE LONGER, MORE FULFILLING AND HEALTHIER LIVES.NO PORTION OF ANY PUBLIC CONTRIBUTION TO GATEWAY GOES TO FUNDRAISING OR ADMINISTRATIVE SALARIES. DUE TO GENEROUS CORPORATE UNDERWRITING OF ADMINISTRATIVE EXPENSES, 99% OF PUBLIC CONTRIBUTIONS RECEIVED ARE APPLIED DIRECTLY TO SUPPORT AGGRESSIVE CANCER RESEARCH AND SCIENTIFIC DEVELOPMENT PROGRAMS. OUR BOARD OF SCIENTIFIC COUNSELORS APPLIES STRINGENT GUIDELINES FOR REVIEWING EACH GRANT APPLICATION, RECOMMENDING TO THE BOARD OF DIRECTORS ONLY THOSE THAT ARE IN KEEPING WITH THE FOUNDATION'S MISSION. THROUGH THIS FORMAL REVIEW PROCESS, GATEWAY ENSURES THAT FUNDING IS GRANTED STRICTLY TO THOSE PROJECTS THAT ARE TRULY INNOVATIVE AND HAVE THE POTENTIAL TO QUICKLY TRANSLATE FROM THE RESEARCHER'S LABORATORY TO THE PATIENT'S BEDSIDE.AS THE NATION'S SECOND MOST DEADLY AND COSTLY DISEASE, CANCER RECOGNIZES NO BOUNDARIES. IN THE BATTLE AGAINST CANCER, GATEWAY IS ON THE FRONTLINES, SUPPORTING CLINICAL RESEARCH INITIATIVES DESIGNED TO ENHANCE QUALITY OF LIFE FOR CANCER PATIENTS, SURVIVORS, AND FAMILIES IN EVERY COMMUNITY NATIONWIDE. GATEWAY FOR CANCER RESEARCH HAS FUNDED OVER 140 STUDIES AND IS CURRENTLY FUNDING 55 STUDIES DEALING WITH NEW AGENT STUDIES, IMMUNOLOGY, NUTRITION, AND GENE THERAPY. BECAUSE WE ARE VIGILANT ABOUT MONITORING OUR CLINICAL RESEARCH STUDIES, WE CAN ASSURE OUR FUNDING PARTNERS THE BEST UTILIZATION OF THEIR CONTRIBUTIONS. WE IDENTIFY AND ENCOURAGE GREATER INTERACTION WITH OUR RESEARCHERS AND ENCOURAGE APPLICATIONS FROM CLINICAL INVESTIGATORS WHO CONSISTENTLY PROVIDE US WITH IMPORTANT PATIENT IMPACT RESEARCH.HISTORICAL DOCUMENTATION OF OUR RESEARCH PROJECTS PROVIDES A WINDOW THROUGH WHICH WE CAN VIEW OUR PAST ACCOMPLISHMENTS AND IMPLEMENT NEW STRATEGIC PROGRAMS THAT REFLECT OUR MISSION - TO FUND MEANINGFUL AND BREAKTHROUGH CLINICAL TRIALS WORLDWIDE THAT HELP PEOPLE LIVING WITH CANCER TO FEEL BETTER, LIVE LONGER AND CONQUER CANCER TODAY! 6241236 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 35 0 0 0 0 0 0 0 1 1 0 0 0 0 X 20 20 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AZ CA CO CT FL IL ME MD MA MI MN MT MO NH NJ NY NC OH OK PA RI SC TN TX VA WA WI X X DIANE KINSLER 8473427450 1336 BASSWOOD ROAD SCHAUMBURG IL 60173 X JANICE ANDERSON DIRECTOR 0.30 X 0 0 0 NAOMI SUTHERLAND DIRECTOR 0.30 X 0 0 0 BRUCE LUBIN DIRECTOR 0.30 X 0 0 0 ROBERT MAYO DIRECTOR 0.30 X 0 0 0 TERESA HALL BARTELS EX-OFFICIO, PRESIDENT 40.00 X X 0 0 0 DENIZ RAZON DIRECTOR 0.30 X 0 0 0 MICHAEL T MULLINS TREASURER 0.30 X X 0 0 0 RICHARD J STEPHENSON CHAIRMAN 0.30 X X 0 0 0 HARLAN TELLER VICE CHAIRMAN 0.30 X X 0 0 0 RHONDA KOKOT SECRETARY 0.30 X X 0 0 0 MARY LOU SMITH DIRECTOR 0.30 X 0 0 0 J TERRY SIMMONS DIRECTOR 0.30 X 0 0 0 SUSAN FLEMING DIRECTOR 0.30 X 0 0 0 HEATHER KANE DIRECTOR 0.30 X 0 0 0 EDWIN ROBERSON DIRECTOR 0.30 X 0 0 0 CHRISTOPHER SURDENIK DIRECTOR 0.30 X 0 0 0 EVA KMIECIC DIRECTOR 0.30 X 0 0 0 JENNIFER STEPHENSON KELLER DIRECTOR 0.30 X 0 0 0 TONY FESTA DIRECTOR 0.30 X 0 0 0 DAN GARMS DIRECTOR 0.30 X 0 0 0 STACIE J STEPHENSON DIRECTOR 0.30 X 0 0 0 0 0 0 0 0 0 0 SHERATON CHICAGO HOTEL & TOWERS 301 EAST NORTH WATER STREET CHICAGO IL 60611 GALA EVENT FACILITY SERVICES 207395 1 88404 2008008 916833 3013245 412591 412591 520814 500120 20694 20694 20694 207395 2008008 207395 0 3446530 0 0 433285 5454837 5454837 703200 703200 19633 19633 BOARD OF SCIENTIFIC COU 63566 63566 BANK AND CREDIT CARD FE 32139 32139 6273375 6241236 32139 0 447205 289223 2011410 481038 130461 106048 37000 51602 10100452 11656008 137429 37101 12863957 12621020 34512 5566657 7978285 6000 47700 5572657 8060497 X 7133013 4456266 158287 104257 7291300 4560523 12863957 12621020 X -2826845 -393654 489722 X X 0 1 X 1 0 X 2476644 3033342 3243122 3036651 3013245 14803004 2476644 3033342 3243122 3036651 3013245 14803004 601501 14201503 21923 18209 226903 352043 433285 1052363 15855367 11785947 0.89570 0.90780 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X 6093185 -393654 2362825 489722 207395 2666288 3426897 19633 19633 3446530 8823962 2362825 207395 2570220 6253742 19633 19633 6273375 PART X, LINE 2: THE FOUNDATION EVALUATES ITS EXPOSURE FOR UNCERTAIN TAX POSITIONS ON AN ANNUAL BASIS. AS OF JUNE 30, 2016 AND 2015, THERE WERE NO LIABILITIES RELATED TO UNCERTAIN TAX POSITIONS. PART XI, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSES NETTED WITH FUNDS GENERATED 207,395. PART XI, LINE 4B - OTHER ADJUSTMENTS: INVESTMENT MANAGEMENT FEES 19,633. PART XII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSES NETTED WITH FUNDS GENERATED 207,395. PART XII, LINE 4B - OTHER ADJUSTMENTS: INVESTMENT MANAGEMENTFEES 19,633. SCHEDULE D, PARTS XII AND XIII, LINES 2D AMOUNTS REPRESENT DIRECT EXPENSES FOR SPECIAL EVENTS HELD AND ARE REFLECTED IN PART VIII ON LINE 8B AGAINST REVENUES FROM FUNDRAISING EVENTS. 1 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION GRANTS FOR CANCER RESEARCH 583200 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION GRANTS FOR CANCER RESEARCH 120000 0 0 0 0 0 0 703200 0 703200 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM CANCER RESEARCH 50000 CASH EUROPE (INCLUDING ICELAND & GREENLAND) CANCER RESEARCH 50000 CASH EUROPE (INCLUDING ICELAND & GREENLAND) CANCER RESEARCH 50000 CASH EUROPE (INCLUDING ICELAND & GREENLAND) CANCER RESEARCH 50000 CASH EUROPE (INCLUDING ICELAND & GREENLAND) CANCER RESEARCH 108200 CASH EUROPE (INCLUDING ICELAND & GREENLAND) CANCER RESEARCH 50000 CASH EUROPE (INCLUDING ICELAND & GREENLAND) CANCER RESEARCH 112500 CASH MIDDLE EAST AND NORTH AFRICA CANCER RESEARCH 120000 CASH EUROPE (INCLUDING ICELAND & GREENLAND) CANCER RESEARCH 112500 CASH 9 0 0 0 0 0 0 0 PART I, LINE 2: PROCEDURES ARE THE SAME AS DOMESTIC GRANTS. SEE SCHEDULE I. GALA FUNDRAISER 2016719 1809324 207395 207395 DESTINATION CURES 94134 94134 3 104550 104550 2215403 2008008 207395 207395 207395 0 1 CHILDREN'S HOSPITAL LOS ANGELES 4650 WEST SUNSET BOULEVARD MS 54 LOS ANGELES CA 90027 951690977 501(C)(3) 133165 CANCER RESEARCH UNIVERSITY OF IOWA COLLEGE OF MEDICINE 200 HAWKINS DRIVE 1528 JCP IOWA CITY IA 52242 237436761 501(C)(3) 33763 CANCER RESEARCH DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BOSTON MA 02115 042263040 501(C)(3) 196252 CANCER RESEARCH UNIVERSITY OF MICHIGAN 1500 E MEDICAL CENTER DRIVE ANN ARBOR MI 48109 386006309 501(C)(3) 177154 CANCER RESEARCH DUKE UNIVERSITY MEDICAL CENTER DUMC 3085 05151A MORRIS BUILDING DURHAM NC 27710 560532129 501(C)(3) 227484 CANCER RESEARCH MEMORIAL SLOAN-KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131624182 501(C)(3) 192667 CANCER RESEARCH CITY OF HOPE 1500 DUARTE ROAD DUARTE CA 91010 953435919 501(C)(3) 295800 CANCER RESEARCH JOHNS HOPKINS UNIVERSITY 1650 ORLEANS STREET CRB1 4M10 BALTIMORE MD 21287 520595110 501(C)(3) 562005 CANCER RESEARCH KARMANOS CANCER INSTITUTE 4100 JOHN R DETROIT MI 48201 386028429 501(C)(3) 525771 CANCER RESEARCH UNIVERSITY OF FLORIDA 1600 SW ARCHER ROAD GAINESVILLE FL 32610 596002052 501(C)(3) 258705 CANCER RESEARCH BOSTON CHILDREN'S HOSPITAL 333 LONGWOOD AVENUE BOSTON MA 02115 042774441 501(C)(3) 128009 CANCER RESEARCH ST JUDE CHILDREN'S HOSPITAL 262 DANNY THOMAS PLACE MEMPHIS TN 38103 620646012 501(C)(3) 266000 CANCER RESEARCH MAYO CLINIC 200 FIRST ST SW ROCHESTER MN 55905 416011702 501(C)(3) 377689 CANCER RESEARCH THE OHIO STATE UNIVERSITY 320 WEST 10TH AVENUE COLUMBUS OH 43210 316025986 501(C)(3) 212443 CANCER RESEARCH WAYNE STATE UNIVERSITY 4100 JOHN R DETROIT MI 48201 386028429 501(C)(3) 10000 CANCER RESEARCH BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA MSBCM 310 HOUSTON TX 77030 741613878 501(C)(3) 10000 CANCER RESEARCH CHILDREN'S HOSPITAL OF PITTSBURGH OF UPMC 4401 PENN AVENUE RANGOS 3RD FLOOR PITTSBURGH PA 15224 251865744 501(C)(3) 10000 CANCER RESEARCH ANN & ROBERT H LURIE CHILDREN'S HOSPITAL OF CHICAGO 225 E CHICAGO BOX 205 CHICAGO IL 60611 362170833 501(C)(3) 10000 CANCER RESEARCH ST VINCENT HOSPITAL AND HEALTH CARE CENTER INC 2001 W 86TH ST INDIANAPOLIS IN 46260 350869066 501(C)(3) 10000 CANCER RESEARCH THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA OFFICE OF SPONSORED PROGRAMS PO BOX 400195 CHARLOTTESVILLE VA 22904 546001796 501(C)(3) 10000 CANCER RESEARCH REGENTS OF THE UNIVERSITY OF COLORARDO MAIL STOP F428 BUILDING 500 RM W1126 13001 E 17TH PLACE AURORA CO 80045 846000555 501(C)(3) 10000 CANCER RESEARCH REGENTS OF THE UNIVERSITY OF MINNESOTA - TWIN CITIES 450 MCNAMARA ALUMNI CENTER 200 OAK STREET SE MINNEAPOLIS MN 55455 416007513 501(C)(3) 10000 CANCER RESEARCH UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION INC THE NUCLEUS BUILDING 300 E MARKET ST SUITE 300 LOUISVILLE KY 40202 611014882 501(C)(3) 9600 CANCER RESEARCH THE CHILDREN'S HOSPITAL ASSOCIATION 13123 E 16TH AVENUE B321 AURORA CO 80045 840166760 501(C)(3) 10000 CANCER RESEARCH VARIETY CHILDREN'S HOSPITAL DBA MIAMI CHILDREN'S HOSPITAL 3100 SW 62 AVENUE MIAMI FL 33155 590638499 501(C)(3) 10000 CANCER RESEARCH CHILDREN'S HEALTHCARE OF ATLANTA INC OFF OF GRANTS ACCOUNTING AND CONTRACTS 1711 TULLIE CIRCLE ATLANTA GA 30329 582367819 501(C)(3) 10000 CANCER RESEARHC MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD UNIT 0462 HOUSTON TX 77030 174601118 501(C)(3) 760059 CANCER RESEARCH MOFFITT CANCER CENTER 12902 MAGNOLIA DR MRC/CANCONT TAMPA FL 33612 593238634 501(C)(3) 106244 CANCER RESEARCH CHILDREN'S HOSPITAL PHILADELPHIA 3501 CIVIC CENTER BLVD PHILADELPHIA PA 19104 231352166 501(C)(3) 250436 CANCER RESEARCH UCLA CANCER CENTER 700 TIVERTON AVENUE FACTOR 11-934 LOS ANGELES CA 90095 952242757 501(C)(3) 299946 CANCER RESEARCH UNIVERSITY OF CALIFORNIA SAN FRANCISCO 400 PARNASSUS AVENUE 0324 SAN FRANCISCO CA 94143 946036493 501(C)(3) 97095 CANCER RESEARCH COLUMBIA UNIVERSITY 1130 ST NICHOLAS AVENUE ROOM 601A NEW YORK NY 10032 135598093 501(C)(3) 234550 CANCER RESEARCH 32 0 PART I, LINE 2: ALL GRANT APPLICATIONS MUST GO THROUGH A RIGOROUS PEER REVIEW PROCESS LED BY OUR BOARD OF SCIENTIFIC COUNSELORS - A DISTINGUISHED BOARD OF RENOWNED SCIENTISTS, PHYSICIANS, RESEARCHERS AND PATIENTS. THROUGH THIS PROCESS, SCIENTISTS INCLUDING EXPERTS IN A PARTICULAR AREA OF CANCER REVIEW AND EVALUATE APPLICATIONS AGAINST A CAREFULLY PRESCRIBED SET OF CRITERIA FOR JUDGING THE SCIENTIFIC MERIT AND POTENTIAL VALUE OF EACH PROPOSED STUDY. THIS REVIEW, NOT ONLY INCLUDES A NUMERICAL GRADING OF OBJECTIVE CRITERIA, IT ALSO INCLUDES A SUBJECTIVE COMMENTARY WITH SUGGESTED MODIFICATIONS. UPON RECOMMENDATION BY THE BOARD OF SCIENTIFIC COUNSELORS, THE APPLICATION IS SUBMITTED TO GATEWAY'S BOARD OF DIRECTORS FOR FUNDING CONSIDERATION. IF APPROVED AND FUNDED, GATEWAY GRANTEES SUBMIT REGULAR REPORTS (I.E., SEMI-ANNUALLY) TO THE RESEARCH GRANTS DEPARTMENT THAT SUMMARIZE THE PROGRESS OF THE FUNDED TRIAL ACCORDING TO THE PRINCIPAL INVESTIGATOR'S PROPOSED TIMELINE AND MILESTONES. ANNUALLY, THE RESEARCH GRANTS TEAM REVIEWS ALL REPORTS SUBMITTED WITHIN THE PAST YEAR AND ASSESSES WHETHER GRANTS ARE "ON TRACK OR "OFF TRACK", WITH RESPECT TO PATIENT ACCRUALS, TIMELY REPORTING, AND PROGRESS TOWARD MEETING STUDY MILESTONES. WHEN NEEDED, THE RESEARCH GRANTS TEAM CONSULTS WITH THE BOARD OF SCIENTIFIC COUNSELORS TO REVIEW AND DEVELOP RECOMMENDATIONS FOR THE BOARD OF DIRECTORS ABOUT THOSE GRANTS THAT THEY DEEM "OFF TRACK". FUNDING CONTINUATION DECISIONS ARE CONTINGENT UPON GOOD PROGRESS/SPENDING. FORM 990, PART VI, SECTION B, LINE 11 FORM 990 IS FIRST REVIEWED BY THE ORGANIZATION'S INTERNAL STAFF AND A SUBSEQUENT REVIEW BY EXECUTIVE STAFF. THE FORM 990 IS THEN REVIEWED BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AND SENT TO EACH CURRENT MEMBER OF THE BOARD FOR THEIR REVIEW AND ACTION. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION'S BOARD MEMBERS AND STAFF ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY DURING A REGULARLY SCHEDULED BOARD MEETING AND DURING THE STAFF MEMBERS ANNUAL PERFORMANCE EVALUATION MEETING. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC VIA IT'S WEBSITE AND OTHER NONPROFIT PUBLICATIONS. FORM 990, PART XI, LINE 9: RETURN OF UNUSED GRANT FUNDS 489,722. FORM 990, PART XII, LINE 2C THE ORGANIZATION'S BOARD OF DIRECTORS ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.